Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Reader in Epigenetics



+44 (0)20 7594 2127j.flanagan




Institute of Reproductive and Developmental BiologyHammersmith Campus





Lab Projects

Dr James Flanagan, completed his PhD in 2002 at the Queensland Institute of Medical Research in Brisbane, Australia, and has pursued postdoctoral work in Cancer Genetics, Epigenetics and Cancer Epigenetics. He was awarded a Breast Cancer Campaign Scientific Fellowship (Imperial, 2009-2014) and Senior Lecturer (2014-2019) and is now Reader in Epigenetics (2019-present) in the Division of Cancer, Dept. of Surgery and Cancer, Faculty of Medicine at Imperial College London.

He was awarded the British Association of Cancer Research Translational Researcher Award in 2011 and the prestigious DataIQ award in 2023 for his work using Shopping Loyalty Cards for early detection of ovarian cancer.  

He is the principal investigator (PI) for the OCA funded programme "Risk and Prevention" and PI of the CRUK funded project "Cancer Loyalty Card Study (CLOCS)"

In 2021 he was appointed as the Director of the MRes Cancer Biology

Google Scholar

orcid logo

Selected Publications

Journal Articles

Flanagan JM, Wilson A, Koo C, et al., 2017, Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patients, Clinical Cancer Research, Vol:23, ISSN:1557-3265, Pages:2213-2222

van veldhoven K, Polidoro S, Baglietto L, et al., 2015, Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis, Clinical Epigenetics, Vol:7, ISSN:1868-7083

Shenker NS, Polidoro S, van Veldhoven K, et al., 2013, Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking, Human Molecular Genetics, Vol:22, ISSN:0964-6906, Pages:843-851

Brennan K, Garcia-Closas M, Orr N, et al., 2012, Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk, Cancer Research, Vol:72, ISSN:0008-5472, Pages:2304-2313

Flanagan JM, Cocciardi S, Waddell N, et al., 2010, DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status, American Journal of Human Genetics, Vol:86, ISSN:0002-9297, Pages:420-433

More Publications